Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Great time for Labs to use German news to their advantage
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(11)
•••
Comment by allibabbaon Feb 27, 2024 11:45am
114 Views
Post# 35901534

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Great time for Labs to use German news to their advantage

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Great time for Labs to use German news to their advantageNice soft bashing Subaru.  Indiva has a price to book of 5.5, same as next leaf which is around 6.  Labs currently trades at a price to book of 0.3.  This is pinned here trading at very low valuation because someone is trying to either make a buyout at .20 look appealing or because someone is trying to do a hostile takeover.  Time will tell I suppose but I'll agree they need to start making some progress on revenue to justify a rise in share price.  I think once that happens and they are cash flow positive, 0.40 is fair.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities